Advertisement

Topics

NetScientific announces first sale of point-of-care test from portfolio company

02:30 EST 15 Feb 2018 | Proactive Investors

The NEATstik test, registered with a CE mark in the second half of 2017, was sold to a research laboratory conducting a respiratory clinical trial for a pharmaceutical company

Original Article: NetScientific announces first sale of point-of-care test from portfolio company

NEXT ARTICLE

More From BioPortfolio on "NetScientific announces first sale of point-of-care test from portfolio company"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...